(R)-2,2,2-Trifluoro-1-(4-chloro-phenyl)-ethylamine hydrochloride, 97%, 1g

2-(5-Methoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

3-(3-Bromo-4-hydroxyphenyl)propanoic acid, 98%, 500mg

tert-Butyl 2-ethynylpiperazine-1-carboxylate, 98%, 1g

((3aR,4R,6R,6aR)-6-(6-Amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl ((R)-2-((tert-butoxycarbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)sulfamate, 95%, 5mg

2-Nitro-5-(trifluoromethyl)phenylacetic acid, 97%, 5g

Methyl 2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 1g

2-Acetyl-5-cyanothiophene, 98.0%, 5g

Fingolimod hydrochloride, 97.0%, 100mg

Indicator paper PEHANON® pH 2.8 - 4.6

3-(3,4-dimethylphenyl)propiophenone, 97.0%, 1g

3-Methoxycyclobutan-1-ol, 95%, 10g

2-(4-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g